Strategic considerations for life sciences partnering
Davis Polk is pleased to host a series of webinars over the coming months focused on legal considerations for life sciences companies. In this first installment, senior members of the Davis Polk IP & Tech Transactions team discuss strategic licensing, collaboration and other partnering considerations, including those that may affect future M&A and financing activities. This program is designed for in-house legal personnel, business development leads, executives and other strategic decision makers.
- Recent trends and considerations for structuring a licensing program
- Approaches to exclusivity
- Transactions with universities and other research institutions
- Addressing the effect of a change of control on licensing partnerships